Cambridge, MA
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.
atavistikbio.comThese are collections Atavistik Bio is a part of. Click on the collection name to view similar companies.
Series Unknown
$40,000,000
Series A
$60,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Atavistik Bio.